(Q37501320)

English

Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008.

scientific article published on 04 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008. (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

0 references

0 references

inflammatory breast cancer

1 reference

based on heuristic

inferred from title

Hassan Errihani

4

object named as

Hassan Errihani

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Nabil Ismaili

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Hind Elyaakoubi

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Youssef Bensouda

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

4 January 2014

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Experimental Hematology & Oncology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

https://scigraph.springernature.com/pub.10.1186/2162-3619-3-1

0 references

Targeted therapy for HER2 positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

Inflammatory breast cancer in Tunisia: epidemiological and clinical trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

Ten-year outcome after combined modality therapy for inflammatory breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

23 August 2017

In regard to Rehman et al. Re: Modern outcomes of inflammatory breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

2 September 2018

Modern outcomes of inflammatory breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

2 September 2018

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3897968

2 September 2018

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

1 reference

https://pubmed.ncbi.nlm.nih.gov/24387242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program

1 reference

https://pubmed.ncbi.nlm.nih.gov/24387242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/2162-3619-3-1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37501320&oldid=2160432737"